Mohamed Attia

Attia joined UNC in 2020 as a T32 postdoctoral fellow in the Carolina Cancer Nanotechnology Training Program. He received his B.S. and M.S. degrees (Honors) in chemistry from Sohag University and Cairo University, Egypt, respectively. He earned his Ph.D. in pharmaceutical chemistry from Strasbourg University, France in 2016. He then joined both the bioengineering and chemistry departments in Clemson University as a postdoc research associate. He mentored both undergraduate and graduate students (a total of 13 students) and led several projects with 6 other postdocs. He also led and coordinated several research collaborations with national and international universities. So far, he published 33 peer-reviewed articles in reputable scientific journals in addition to several other ongoing drafted articles. Most recently, two press releases have been issued and posted on Clemson newsstand about his work and winning the 2020 Clemson University distinguished postdoc award. He served as the Vice President of Clemson University Postdoc Association. He served as a referee for more than 70 articles for over 23 peer-reviewed journals. He also serves as editorial board member in European Journal of Pharmaceutical Research, and guest editor for a special issue “Polymers for Biomedical Imaging and Therapy” in Polymers, MDPI.

The central theme of his research, in cancer nanomedicine, aims to design smart vectors (i.e. polymer, lipid, and inorganic nanomaterials) to deliver a wide range of therapeutic/contrast agents and targeting moieties, and to fabricate multifunctional nanoparticles for combinatory therapy and theranostic applications using cutting edge technologies. His long-term research career is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic.

Mohamed’s Publications